drugset / Trial / NCT06799416
A Study to Assess the Safety of ARGX-109 in Healthy Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
This study aims to assess the safety of ARGX-109 in healthy adults. Another aim is to measure the amount of ARGX-109 in the blood over time to learn how it moves through the body and acts in the body. Each participant will remain in the study for approximately 20 weeks.
Timeline
- Start
- 2025-01-14
- Primary completion
- 2025-08-08
- Completion
- 2025-08-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARGX-109 | Unknown | — | Subcutaneous |
Indications
No indication recorded.